Izinkinga ze-Urinary Tract Men

Imibandela Yonke Umuntu Kufanele Yazi Ngayo

Izinkinga zesinambambili nezokuvuthwa zingathatha amadoda kwanoma yisiphi ubudala futhi nganoma yisiphi isizathu sezizathu. I-urinary tract yilona uhlelo olususa udoti nokuphuma ngokweqile emzimbeni ngendlela yomchamo. Ukuze ukuvuthwa okujwayelekile kwenzeke, zonke izingxenye zesistimu zidinga ukusebenza ndawonye ekuxhumaneni.

Lokhu kuhlanganisa, ekuhlahleni, izinso , i-ureter (ehlanganisa izinso kwesinye isisu), isisu, nesisu (lapho umchamo uphuma emzimbeni ngokusebenzisa ipeni).

Uma noma yiliphi lala malungu elimele, elithelelekile, noma eligulayo, uhlelo lungahle luphule futhi lubonakaliswe ngezimpawu zamagciwane.

Izinkinga eziyisithupha ezivame kakhulu zomgudu eziphathelene namadoda yizi:

Ukunciphisa Umkhiqizo we-Urine

Ukunciphisa umkhiqizo we-urine kungumphumela wokucindezela noma ukuvinjelwa kweziteshi lapho umchamo ophuma khona emzimbeni. Kungase kubangelwe ukuphelelwa amandla kwamanzi, i- prostate ekhulisiwe , noma imithi efana ne- diuretics ("amaphilisi amanzi"), anticholinergics , kanye nama-antibiotic athile. Ngokuvamile, ukunciphisa umchamo kungaba umphumela wokulahleka kwegazi, ukutheleleka kwamagciwane (UTI) , noma ukulimala okubuhlungu.

Ama-Stones e-Bladder

Amatshe ekhanda ayenzeka cishe wonke amadoda. Ngokuphambene nenkolelo evamile, akuyona into efanayo neyezinso zezinso futhi ajwayelekile kakhulu. Amatshe okugcoba abangwa yi-concentration ephezulu ye-urine esithombeni esingabangela ukwakhiwa kwamakhemikhali aqinile.

Amatshe okugcoba angavimbela ukugeleza kwe-urine futhi agxeke uketshezi lwesisu. Izimpawu zihlanganisa ubuhlungu, igazi emcimbini (i- hematuria ), ukuvuthwa okubuhlungu (i- dysuria ), kanye nesifiso sokuvuthwa (ukuphuthuma komchamo).

Ukucindezela Ukungasebenzi Kwe-Urinary

Nakuba kuvame kakhulu kubantu besifazane, ukucindezeleka ukungabi nokucindezeleka kungenzeka emadodeni lapho imisipha ehlose ukulawula ibambe umchamo ibe buthakathaka futhi ibangele ukulahlekelwa umchamo okungenhloso.

Ukucindezeleka ukungahambisani nakho kungenzeka uma umsebenzi noma ukunyakaza okungokomzimba-njengokukhwehlela, ukukloloda, ukuhleka, noma ukuphakamisa izinto ezinzima-izindawo ezicindezelayo esibelethweni.

I-Cancer Cancer

Umdlavuza wesibeletho yilona uhlobo lwesihlanu oluvame kakhulu lomdlavuza e-United States kanti enye eqala ikakhulukazi emgqeni wesibindi. I-Hematuria, i-dysuria nokuphuthumayo komchamo yizimpawu ezintathu ezivame kakhulu zomdlavuza wesibeletho. Amadoda, abadala asebekhulile, abaseCaucasus, kanye nabantu abanomlando womndeni wesifo somdlavuza wesinye isisengozini esikhulu.

Urethritis

Urethritis ukuvuvukala kwe-urethra. Kungabangelwa ama-bacterium kanye nama-virus, kuhlanganise nokudluliswa ngokocansi . Abesilisa abaneminyaka engama-20 kuya kwezingama-35 basengozini enkulu, ikakhulukazi labo abanezixuku eziningi zobulili kanye nomlando wokuziphatha okuyingozi (kubandakanya ubulili obungenalo ikhondomu ). Uma une-urethritis, ungase uzwe umuzwa ovuthayo uma uchama noma ukhululeka emaseni kusuka e-penis. Kwezinye izimo, i-urethritis ingenzeka ngenxa yesizathu esingaziwa, isimo esibhekwa njengama -urethritis okungewona oqondile (NSU) .

Ukutheleleka Kwama-Urinary Tract

Emadolobheni ama-4 abesifazane abaningi bathola ukutheleleka kwe-urinary (UTIs) njengamadoda. Ziyi-infection ejwayelekile kunazo zonke umuntu angathola futhi akwenze lapho amabhaktheriya engena nge-urethra bese eqala ukuphindaphinda esithombeni.

Izimpawu zazibandakanya i-dysuria, ukuphuthuma komchamo, ukuvutha kwamanzi kanye / noma umchamo ocolile , ubuhlungu emagqeni, imfiva, kanye ne-malaise. I-UTIs ivame kakhulu emadodeni amadala, ikakhulukazi labo abaye babhekana nokulimala emgodini we-urinary (ngokuvamile ngenxa yokugula kwangaphambilini noma ukutheleleka) noma banenkinga yokuzalwa kwengane ye-urethra.

> Imithombo:

> Hollingsworth, J. noWilt, T. "Izimpawu ezingaphansi kwe-urinary kumadoda." BMJ. 2014; 349: g4474. I-DOI: 10.1136 / bmj.g4474.

> Schaeffer, A. noNicolle, L. "Izifo Zama-Urinary Amagciwane Kwabesilisa Abadala." N Engl J Med. 2016; 374: 562-71. I-DOI: 10.1056 / NEJMcp1503950.